Treatment of Severe Iron Deficiency Anemia with the Traditional Koryo Medicine—Ginseng Anticancer Composite Drug (GACCD)

Authors

  • Kum-Chol Chang Abdominal Surgery Department, Pyongyang Medical College, Kim Il Sung University
  • Ae-Sun Ri General Laboratory, Pyongyang Medical College Hospital, Kim Il Sung University, Central District, Pyongyang, Democratic Peoples’ Republic of Korea
  • Chun-Ok Kim Department of Ingredients, Traditional Koryo Medicine Institute, the Academy of Koryo Science, Tongdaewon Distirct, Pyongyang, Democratic Peoples’ Republic of Korea
  • Myong-Sok Pae Department of Ingredients, Traditional Koryo Medicine Institute, the Academy of Koryo Science, Tongdaewon Distirct, Pyongyang, Democratic Peoples’ Republic of Korea
  • Myong-Chol Chang Abdominal Surgery Department, Pyongyang Medical College, Kim Il Sung University, Central District, Pyongyang, Democratic Peoples’ Republic of Korea

DOI:

https://doi.org/10.37591/rrjooh.v8i3.1690

Abstract

In contrast to many medical conditions whose discovery carries a specific date often associated with a particular investigator, iron deficiency is an ancient disorder that stretches to the dawn of human history. In recent years, Iron deficiency anemia (IDA) is a disease that has reached epidemic proportions affecting countries worldwide, when it commonly begins from denutrition. Iron deficiency produces microcytic hypochromic red cells and substantially depresses both the mean corpuscular volume (MCV) and the mean corpuscular hemoglobin concentration (MCHC). The peripheral blood reticulocyte counts are in the normal range, but it sometimes increases a little. The number of nucleated cell could rise slightly in the bone marrow examination. Total iron-binding capacity (TIBC) may be elevated while the level of the serum iron may be depressed. In this report, we diagnosed one 13-year-old female with severe anemia as having IDA by symptoms, physical examination and laboratory tests. Thus, she took the traditional Koryo medicine— Ginseng anti-cancer composite drug (GACCD). Approximately one month later after administration of GACCD, the blood examination and symptoms began to improve. Furthermore, she was sufficiently recovered to go to work after 45 days. Therefore, we considered that GACCD could be one of the potentially advantageous choices in case of IDA.

 

Keywords: Ginseng anti-cancer composite drug (GACCD), herbal medicine, Iron deficiency anemia (IDA), phytotherapy, traditional medicine

 

Cite this Article

Kum-Chol Chang, Ae-Sun Ri, Chun-Ok Kim, Myong-Sok Pae, Myong-Chol Chang. Treatment of Severe Iron Deficiency Anemia with the Traditional Koryo Medicine—Ginseng Anticancer Composite Drug (GACCD). Research & Reviews: Journal of Oncology and Hematology. 2019; 8(3): 13–17p.

Downloads

Published

2019-12-16

Issue

Vol. 8 No. 3 (2019)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.